Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia

More about Open Access at the Crick

Abstract

Niche hijack by malignant cells is considered to be a prominent cause of disease relapse. Barbier and colleagues uncover (E)-selectin as a novel mediator of malignant cell survival and regeneration which, upon blockade, has the potential to significantly improve therapeutic outcomes.